EARLY ENDOTHELIUM ACTIVATION AND POLYMORPHONUCLEAR CELL INVASION PRECEDE SPECIFIC NECROSIS OF HUMAN-MELANOMA AND SARCOMA TREATED BY INTRAVASCULAR HIGH-DOSE TUMOR-NECROSIS-FACTOR-ALPHA (RTNF-ALPHA)

被引:156
作者
RENARD, N
LIENARD, D
LESPAGNARD, L
EGGERMONT, A
HEIMANN, R
LEJEUNE, F
机构
[1] CHU VAUDOIS,CPO,CH-1011 LAUSANNE,SWITZERLAND
[2] FREE UNIV BRUSSELS,INST JULES BORDET,DEPT PATHOL ANAT,BRUSSELS,BELGIUM
[3] FREE UNIV BRUSSELS,INST JULES BORDET,ONCOL & EXPTL SURG LAB,BRUSSELS,BELGIUM
[4] DR DANIEL DEN HOED CANC CTR,ROTTERDAM,NETHERLANDS
关键词
D O I
10.1002/ijc.2910570508
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Twenty-seven patients treated with high-dose rTNF alpha, IFN gamma and melphalan by isolated limb perfusion were histologically documented. There were 20 cases of melanoma-in-transit metastases and 7 cases of high-grade soft-tissue sarcoma. Biopsies were taken before IFN gamma, after IFN gamma, before TNF alpha and between 2 hr and 60 days after the TNF alpha perfusion. Immunohistochemistry was performed for adhesion molecules ICAM-I, ELAM-I (E selectin), VCAM-I and PECAM. During the first hours after beginning perfusion, the endothelial cells of the tumour capillaries appeared swollen. Significant tumour necrosis was already observed 3 hours after the perfusion in melanoma cases. The overall predominant feature was coagulative necrosis associated or not with haemorrhagic necrosis. TNF alpha induced increased expression of ELAM-I and VCAM-I adhesion molecules on intratumoral endothelial cells. The activated tumour vessels were progressively destroyed. Significant intravascular recruitment of polymorphonuclear cells (PMNs) was observed 3 hr after starting TNF alpha; it was followed by diapedesis and tumour colonization 3 days later. T lymphocytes and macrophages were detected during the first 7 days and B lymphocytes during the second week. Melanoma in transit metastases treated with alkylating agent alone did not show significant necrosis and did not express high levels of adhesion molecules (ELAM-I,VCAM-I) nor infiltration by PMN. (C) 1994 Wiley-Liss, Inc.
引用
收藏
页码:656 / 663
页数:8
相关论文
共 18 条
[1]   MOLECULAR AND CELLULAR PROPERTIES OF PECAM-1 (ENDOCAM/CD31) - A NOVEL VASCULAR CELL CELL-ADHESION MOLECULE [J].
ALBELDA, SM ;
MULLER, WA ;
BUCK, CA ;
NEWMAN, PJ .
JOURNAL OF CELL BIOLOGY, 1991, 114 (05) :1059-1068
[2]   PLASMINOGEN ACTIVATORS, PLASMINOGEN-ACTIVATOR INHIBITORS AND PROCOAGULANT ANALYZED IN 20 HUMAN-TUMOR CELL-LINES [J].
CAJOT, JF ;
KRUITHOF, EKO ;
SCHLEUNING, WD ;
SORDAT, B ;
BACHMANN, F .
INTERNATIONAL JOURNAL OF CANCER, 1986, 38 (05) :719-727
[3]   THE EORTC MELANOMA GROUP EXCHANGE PROGRAM - EVALUATION OF A MULTICENTER MONOCLONAL-ANTIBODY STUDY [J].
CARREL, S ;
DORE, JF ;
RUITER, DJ ;
PRADE, M ;
LEJEUNE, FJ ;
KLEEBERG, UR ;
RUMKE, P ;
BROCKER, EB .
INTERNATIONAL JOURNAL OF CANCER, 1991, 48 (06) :836-847
[4]   ENDOTOXIN-INDUCED SERUM FACTOR THAT CAUSES NECROSIS OF TUMORS [J].
CARSWELL, EA ;
OLD, LJ ;
KASSEL, RL ;
GREEN, S ;
FIORE, N ;
WILLIAMSON, B .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1975, 72 (09) :3666-3670
[5]  
Cotran R, 1988, ENDOTHELIAL CELL BIO, P335
[6]  
EGGERMONT AMM, 1993, TUMOR NECROSIS FACTOR : MOLECULAR AND CELLULAR BIOLOGY AND CLINICAL RELEVANCE, P239
[7]   A PHASE-I TRIAL OF INTRAVENOUSLY-ADMINISTERED RECOMBINANT TUMOR NECROSIS FACTOR-ALPHA IN CANCER-PATIENTS [J].
FEINBERG, B ;
KURZROCK, R ;
TALPAZ, M ;
BLICK, M ;
SAKS, S ;
GUTTERMAN, JU .
JOURNAL OF CLINICAL ONCOLOGY, 1988, 6 (08) :1328-1334
[8]  
FIERS W, 1987, CIBA F SYMP, V131, P109
[9]  
LE JM, 1987, LAB INVEST, V56, P234
[10]  
LEDER L-D, 1979, American Journal of Dermatopathology, V1, P39